D.A. Davidson & Co. Viatris Inc Transaction History
D.A. Davidson & Co.
- $15.6 Billion
- Q4 2025
A detailed history of D.A. Davidson & Co. transactions in Viatris Inc stock. As of the latest transaction made, D.A. Davidson & Co. holds 28,098 shares of VTRS stock, worth $301,210. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,098
Previous 19,480
44.24%
Holding current value
$301,210
Previous $192,000
56.77%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding VTRS
# of Institutions
1,148Shares Held
966MCall Options Held
7.74MPut Options Held
2.49M-
Vanguard Group Inc Valley Forge, PA138MShares$1.48 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$993 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD84.1MShares$901 Million0.09% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az69.3MShares$743 Million3.68% of portfolio
-
State Street Corp Boston, MA55.7MShares$597 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $13B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...